Communications publiées lors de congrès ou colloques nationaux et internationaux (118)
  1. 9. Robette, G., Van Driessche, B., Fauquenoy, S., Kula, A., Delacourt, N., Vanhulle, C., Schwarzer, C., Burny, A., Rohr, O., & Van Lint, C. (2014). Identification and characterization of new functional Sp1 sites located in the R region of the Human T-lymphotropic Virus 1 (HTLV-1) Long Terminal Repeat: Alterations of Metabloci pathways as therapeutic targets. Abstract of Metabolism 2014 (29-31 Jan, 2014: Esch-Sur-Alzette, Luxembourg)
  2. 10. Van Driessche, B., Robette, G., Guiguen, A., Vanhulle, C., Burny, A., Rohr, O., & Van Lint, C. (2013). Identification and characterization of new functional Sp1 sites located in the R region of the Human T-lymphotropic Virus 1 (HTLV-1) Long Terminal Repeat. Abstract of the 16th International Conference on Human Retrovirology : HTLV & related Viruses 16th International Conference on Human Retrovirology : HTLV & related Viruses(Montréal, Canada)
  3. 11. Van Lint, C. (2013). HIV-1 reservoirs and epigenetic control of viral postintegration latency : implications for therapuetic interventions. Abstract of HIVERA Think Tank Meeting (14 Jan, 2013: Paris, France)
  4. 12. Van Lint, C. (2013). Approches moléculaires pour éliminer les réservoirs du VIH. Abstract of Journées Québécoises VIH (14-15 March, 2013: Montréal, Canada)
  5. 13. Van Lint, C. (2013). HIV-1 reservoirs and epigenetic control of viral postintegration latency : implications for therapeutic interventions. Abstract of IAS "Towards an HIV cure" Think Tank Meeting (21-23 March, 2013: Paris, France)
  6. 14. Darcis, L., Kula, A., Bouchat, S., Kabeya, K., Delacourt, N., Vanhulle, C., Gatot, J.-S., Vaira, D., Burny, A., Herbein, G., Clumeck, N., Rohr, O., Moutschen, M., Rouzioux, C., De Wit, S., & Van Lint, C. (2013). Synergistic activation of HIV-1 expression by comounds targeting the positive transcription elongation factor b (P-TEFb) and by inducers of the NF-kB signaling pathway. Abstract of EACS 2013 (16-19 Oct, 2013: Brussels, Belgium)
  7. 15. Van Lint, C. (2013). Molecular mecanisms of HIV-1 post-integration latency. Abstract of "30 years of HIV Science Symposium" (May 21-23, 2013: Paris, France)
  8. 16. Van Lint, C., Cherrier, T., Van Driessche, B., Vanhulle, C., Robette, G., Delacourt, N., Schwarzer, C., & Rohr, O. (2013). Dual role of the cellular cofactor CTIP2 in HIV-1 latency. Abstract of 14th European AIDS conference (16-19 Oct, 2013: Brussels, Belgium)
  9. 17. Van Lint, C. (2012). Comment cibler le réservoir ? Abstract of 6ème Conférence Francophone VIH/SIDA (AFRAVIH) (25-28 March, 2012: Genève, Switzerland)
  10. 18. Van Lint, C. (2012). Deciphering the HIV persistence. Abstract of 17th International Symposium HIV & Emerging Infectious Diseases (ISHEID) (23-25 May, 2012: Marseille, France)
  11. 19. Van Lint, C. (2012). Epigenetic control of human immunodeficiency virus type 1 (HIV-1-) latency : implications for therapeutic interventions. Abstract of the Belgian Microbiology Society Symposium "Posttranscriptional regulation and epigenetics in microorganisms" (30 Nov, 2012: Brussels, Belgium)
  12. 20. Ansseau, E., Charron, S., Guiguen, A., Van Lint, C., Coppee, F., & Belayew, A. (2011). YY1 and MyoD are transcriptional activator and inhibitor, respectively, of the DUX4 gene that causes facioscapulohumeral muscular dystrophy (FSHD). Abstract of International Congress of Myology (2011: Lille, france)
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 Suivant >>